Select Page

All News

MeCRU Research Unit Officially launched as Paediatric COVID-19 VACCINE Trial Site

MeCRU Research Unit (MeCRU), at SMU has been officially launched as the research site for Phase III Paediatric COVID-19 Vaccine study conducted by the Numolux Group and Sinovac on 10 September 2021. The very first child and the second one had the honor to receive their jabs which kick started the study.

Related News

SMU orientation sets a confident tone for first-time entering students

SMU orientation sets a confident tone for first-time entering students

Sefako Makgatho Health Sciences University (SMU) launched its 2026 academic year with a high-energy, purpose-driven Orientation Programme for first-time entering (FTEN) students, signalling not just the start of university life, but the beginning of a demanding and...